January 16, 2018
- FDA Drug Safety Podcast: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drugs@FDA Data Files (updated)
- FDA Drug Shortages
- Atenolol Tablets (Updated - Currently in Shortage)
- Carbidopa and Levodopa Extended Release Tablets (Updated - Currently in Shortage)
- Dexrazoxane Injection (Updated - Currently in Shortage)
- Guanfacine Hydrochloride Tablets (Updated - Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated - Currently in Shortage)
- National Drug Code Directory (updated)
- Varubi (rolapitant) injectable emulsion
- Dear Health Care Provider Letter: Anaphylaxis, anaphylactic shock and other serious hypersensitivity reactions associated with the use of Varubi (rolapitant) injectable emulsion (PDF - 431 KB)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario